Ramesh Eluri, MD
Psychiatry · Philadelphia, PANPI 1497706097
Payments from drug & device makers
Across 711 payments — averaging $119.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$30K
- Alkermes, Inc.$18K
- Supernus Pharmaceuticals, Inc.$12K
- E.r. Squibb & Sons, L.L.C.$8K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$6K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$3K
- plus $8K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 143 | $29,533 |
| Alkermes, Inc. | 77 | $18,416 |
| Supernus Pharmaceuticals, Inc. | 39 | $11,731 |
| E.r. Squibb & Sons, L.L.C. | 21 | $8,386 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 9 | $5,621 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 30 | $3,088 |
| Otsuka America Pharmaceutical, Inc. | 78 | $1,893 |
| Johnson & Johnson | 67 | $1,321 |
| Lundbeck LLC | 41 | $592 |
| Vanda Pharmaceuticals Inc. | 24 | $572 |
| Takeda Pharmaceuticals U.S.A., Inc. | 28 | $554 |
| Neurocrine Biosciences, Inc. | 22 | $535 |
| Teva Pharmaceuticals USA, Inc. | 24 | $505 |
| Axsome Therapeutics, Inc. | 21 | $462 |
| Sunovion Pharmaceuticals Inc. | 14 | $241 |
| Indivior Inc. | 9 | $190 |
| Jazz Pharmaceuticals Inc. | 7 | $147 |
| Corium, LLC | 5 | $109 |
| Shire North American Group Inc | 7 | $104 |
| Tris Pharma Inc | 6 | $102 |
| Adlon Therapeutics L.p. | 5 | $91 |
| Avanir Pharmaceuticals, Inc. | 6 | $89 |
| Evoke Pharma, Inc. | 1 | $85 |
| Bausch Health US, LLC | 5 | $83 |
| Harmony Biosciences LLC | 3 | $82 |
| Braeburn Inc. | 3 | $78 |
| Ironshore Pharmaceuticals Inc. | 3 | $71 |
| Orexo US, Inc. | 4 | $51 |
| Collegium Pharmaceutical, Inc. | 3 | $51 |
| Neos Therapeutics, LP | 2 | $48 |
| Neuronetics, Inc. | 2 | $31 |
| OWP Pharmaceuticals, Inc. | 2 | $31 |
How this compares
$84,891 in reported general payments places this provider in the 95th percentile of 1,838 psychiatry providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Philadelphia
- Steven ArnoldPhiladelphia$4.1M
- Michael ThasePhiladelphia$2.2M
- Daniel WeintraubPhiladelphia$647K
- Yvette ShelinePhiladelphia$442K
- Kyle KampmanPhiladelphia$355K
- Christian KohlerPhiladelphia$172K
- Freddy AliPhiladelphia$107K
- Stanley CaroffPhiladelphia$105K
- Richard JaffePhiladelphia$101K
- John LaurielloPhiladelphia$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.